How many investments has Qbic Fund made?

Qbic Fund has 33 tracked investments, including 5 dated in the last 24 months.

What stage does Qbic Fund invest at?

Qbic Fund invests at the Pre-Seed, Seed, Series A stages.

What sectors does Qbic Fund focus on?

Qbic Fund focuses on Advanced Manufacturing, AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Crypto & Web3, Deep Tech, Digital Health, Energy, FoodTech, Hardware, Healthtech, Impact & Social Good, IoT, Medical Devices, Mobility & Transportation, New Materials, Quantum Computing, Robotics, SaaS, Sector Agnostic, Semiconductors, Space Tech.

Where is Qbic Fund located?

Qbic Fund is headquartered in St-Denijs-Westrem, BE.

Does Qbic Fund lead rounds?

Qbic Fund typically participates in rounds rather than leading them.

Who does Qbic Fund co-invest with?

Qbic Fund most often shares deals with imec.istart, PMV, Agri Investment Fund, among 23 tracked co-investors.

Qbic Fund

Venture capital

St-Denijs-Westrem · Pre-Seed–Series A · 18 people tracked

Also known as Qbic

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Qbic Fund

1,378 people in our graph share verified history with the Qbic Fund team — schools, employers, funds. One of them is your warm intro.

Geoffrey D'hondtunlockedknows Katleen Vandersmissen · together at Thirona (overlapped)

knows the team · via Medpace

knows the team · via Ordina

×2knows the team · via Barco

knows the team · via Harvard Medical School and Massachusetts General Hospital

×2knows the team · via Heran Partners

✨ Fox Verdict

Investment thesis

Qbic is a seed and early-stage venture capital fund focused on valorizing research emerging from its network of knowledge partners, which include universities, research institutes and hospitals across Belgium. It invests in two main types of companies: knowledge-partner spin-offs founded on technological innovations originating at partner institutions, and start-ups with strong R&D collaborations with a knowledge partner, structured through joint development contracts, clinical studies or IP license agreements. Its portfolio spans biotech, healthtech, deeptech and software, with a strong emphasis on impact, sustainability and translating scientific breakthroughs into commercial ventures.

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Pre-Seed–Series A

St-Denijs-Westrem, BE

Leads rounds

Follows

Instruments

Equity

Founded

2012

Last 12 months

5 investments

AUM

$205.2M

Tracked investments

Team · 18 people

from the firm's website & public directories

Marc Zabeau· Managing Partner Qbic I· Ghent Metropolitan Areain

marc.zabeau@qbicfund.be

Martin De Prycker· Managing Partner Qbic I· Ghent Metropolitan Areain

Veteran technology executive who held senior roles at Alcatel-Lucent, served as CEO of Barco and founded silicon photonics startup Caliopa. He joined Qbic I as a managing partner in 2012.

martin.deprycker@qbic.be

Cédric Van Nevel· Partner Qbic II & III, Co-founder Qbic III· Ghent Metropolitan Areain

Former BCG strategy consultant with energy-sector management experience at Fluxys who later led Bekaert's venturing activities before joining Qbic. He holds an MSc in Electronics from Ghent.

cedric.vannevel@qbic.be

Sofie Baeten· Managing Partner Qbic II & III, (Co-)founder Qbic II & III· Ghent Metropolitan Areain

PhD with a long venture capital track record, previously managing partner at Capital-E, Gimv and Baekeland Fonds II. She holds several board/chair positions in portfolio companies and holds degrees from Ghent, Leuven and Vlerick.

sofie.baeten@qbic.be

Steven Leuridan· Partner Qbic II & III, Co-founder Qbic IIIin

PhD and CFA Charterholder focused on projects combining engineering and finance, especially medical applications. He co-founded sleep-products startup Equilli and previously worked with a Belgian family office.

steven.leuridan@qbic.fund

Guy Huylebroeck· Partner Qbic Iin

guy.huylebroeck@qbic.be

Stéphanie Put· Investment Manager

stephanie.put@qbic.be

Delphine Hajaji· Advisory Board Expert· Ghent Metropolitan Areain

Delphine Hajaji is co-founder and CEO of an undisclosed venture and brings over 20 years of experience in health technology, pharmaceuticals, and healthcare commercialization. She has held board positions and served as an advisor to multiple startups and scale-ups, including companies in EU Commission and EIT Health programs. Her background includes leading local and international teams across digital health, marketing strategy, and venture capital.

Dirk Wauters· Advisory Board Expert· Antwerp Metropolitan Areain

Dirk Wauters is a visiting professor of innovation management at KU Leuven and a business angel investor. He has held senior executive positions at Alcatel and Siemens, serving as CEO of Siemens Networks and VRT, Belgium's public service broadcaster, where he directed operational turnarounds and growth initiatives. His background includes founding Silvar-Lisco, KU Leuven's first spin-off, which listed on Nasdaq in 1984, and five years working in Silicon Valley.

Ellen Crabbe· Advisory Board Expert· Ghent, Flemish Region, Belgiumin

Eric Peeters· Advisory Board Expert· Zwevegem, Flemish Region, Belgiumin

Eric Peeters is Division CEO of Bekaert Construction and a member of the company's Group Executive Committee. He has held leadership and P&L responsibility across multiple industries, including chemicals, home and personal care, construction, solar energy, lighting, industrial manufacturing, coatings, electronics, and automotive. Peeters serves as Vice Chair of the American Cleaning Institute, Chairman of the Energy Materials Industrial Research Initiative, a board member of the Global Silicone Council, and an investment committee member at Qbic, a venture capital fund based in Ghent. He has worked professionally in Belgium, the United Kingdom, the United States, and Switzerland.

Johan Brants· Advisory Board Expert· Ghent Metropolitan Areain

Johan Brants is a European, Belgian, and Dutch patent attorney and founding partner of Brantsandpatents, a firm offering intellectual property services including prosecution, litigation, portfolio management, and enforcement advice. The firm maintains offices in Ghent and Brussels and focuses on chemistry, biotechnology, pharmaceutical, and mechanical engineering patent matters. Brants and his firm have been recognized in the IAM Patent Guide's World's Leading Patent Practitioners.

Katleen Vandersmissen· Advisory Board Expert· Antwerp Metropolitan Areain

Katleen Vandersmissen is Managing Partner at HERAN Partners, a venture capital firm focused on European HealthTech. Her background spans industry, management consultancy, and the venture capital and private equity sectors, with experience across life sciences, technology, and recycling and materials. Her areas of expertise include strategic and business planning, execution, negotiations, people management, and coaching.

katleen.vandersmissen@heranpartners.com

Pierre Rion· Advisory Board Expert· Thorembais-les-Béguines, Walloon Region, Belgiumin

Sophie Manigart· LP Committee Chair· Ghent Metropolitan Areain

Sara Vandenwijngaert· Chief Scientific Director Qbic II & III· Ghent, Flemish Region, Belgiumin

Life sciences researcher with a PhD in Cardiovascular Medicine who conducted research at Leuven and Harvard Medical School and managed clinical science at Boston's One Brave Idea initiative before joining Qbic.

sara.vandenwijngaert@qbic.be

Tom Smets· Investment Associate Qbic II & III· Ghent Metropolitan Areain

Life sciences background with interest in biotech and IT, previously worked at Pfizer and J&J and led an audit team at Ordina before joining Qbic.

tom.smets@qbic.be

Vincent Lenders· Investment Associate Qbic II & III· Antwerp, Flemish Region, Belgiumin

PhD in Biomedical Sciences focused on nanotechnology for biomedical applications, with research experience at imec, Leuven and Harvard.

vincent.lenders@qbic.be

What they invest in

from 21 of 33 portfolio companies

Biotech ×10Healthtech ×8Medical Devices ×8AI & Machine Learning ×7Deep Tech ×7IoT ×6SaaS ×6Digital Health ×4

HQs:Belgium×13

Who they back

founder profiles across 8 portfolio companies

50%

solo founders

4 of 8 mapped founding teams

repeat founders

of 11 founders with career history

Founding team size:solo founder×42 founders×24+ founders×2

What their founders studiedfrom 10 founders with field-of-study data

Engineering ×3Life Sciences ×3Business & Management ×2Medicine ×2

Where their founders worked beforefrom 11 founders with career history

Bio Base Europe Pilot Plant ×3Artesis Hogeschool Antwerpen ×2DASH7 Alliance ×2Ghent University ×2VIB ×2

Investments · 33 tracked

founders shown can be your intro path

By year:2026 · 5 2023 · 2 2016 · 1 2015 · 19 dated

Obulytixobulytix.com in✓ verified

Obulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGhent, BE

Yves Briers(Scientific Founder)in

Co-investorsBoehringer Ingelheim Venture Fund

ABSCINTabscint.com

ABSCINT develops non-invasive in vivo PET imaging diagnostics using single-domain antibodies (sdAbs) as radiolabeled targeting agents, including an anti-HER2 PET tracer for whole-body imaging.

BiotechHealthtechMedical Devices

Accelleranaccelleran.com in 𝕏Feb 2026

Accelleran develops software for private 4G/5G radio access networks, including O-RAN compliant components for building and testing private cellular networks.

Deep TechEnterprise SoftwareIoTSaaS

Co-investorsAngelwise Capital-E Cogito Capital Partners Bpifrance Matterwave Ventures

Aloxyaloxy.io in

Aloxy develops industrial IoT solutions including sensors, gateways, and middleware for the chemical, oil and gas, and process industries.

Advanced ManufacturingDeep TechEnterprise SoftwareHardwareIoTAntwerp, BE

Maarten Weyn inGlenn Ergeerts in

Co-investorsimec.istart Imec.xpand Dow Venture Capital Innovation Fund sa/nv

AmphiStaramphistar.com in

AmphiStar develops biosurfactants through advanced bioprocessing and fermentation for industrial applications including chemicals and consumer goods.

AgTechBiotechCircular EconomyCleantechClimate TechNew MaterialsGhent, BE

Sophie Roelants(Co-founder & COO)inBernd Everaert(Co-founder & Executive Director)inKarolien Maes(Co-founder and Head of Bioprocessing and Scale Up)inSofie De Maeseneire(Co-founder and Head of Synthetic Biology)Pierre-Franck Valentin(CEO)in Wim Allegaert(CFO)in

Co-investorsEuropean Circular Bioeconomy Fund PMV

Animabanimab.com

Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.

AgTechBiotechDeep TechHealthtechGhent, BE

Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De Greve Alain Wille(CEO)in

Co-investorsAgri Investment Fund Seventure Partners PMV V-Bio Ventures AIF VIB

Axithraaxithra.com in 𝕏Sep 2023

Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care.

Deep TechDigital HealthHealthtechMedical Devices

Co-investorsimec.xpand Kurma Partners White Fund Wallonie Entreprendre

Cascadorcascador.health in

Cascador Health provides real-world data analytics and clinical research services to pharmaceutical companies and healthcare organizations, focusing on market access, clinical evidence generation, and therapy adoption in healthcare.

BiotechData & InfrastructureDigital HealthHealthtechMedical Devices

Philip Taillieu(Founder & CEO)

Co-investorsimec.istart PMV Volta Ventures

Crowd Scancrowdscan.be in 𝕏

CrowdScan builds a wireless sensor network using low-energy radio waves to measure and predict crowd density and movement in real time for public transport, city centers, and events.

GovTechHardwareIoT

Anton Dierickx(Founder)in

Co-investorsimec.istart

Drivendriven.work inJul 2026

Driven is an AI-powered sales commission management platform that automates commission calculations, reviews deal disputes, and generates performance reports and audit trails.

AI & Machine LearningSaaSSales Tech

Co-investorsPitchdrive Entourage Ventures

Driventrustdriven.comJul 2026

TrustDriven provides integrated software products for nonprofits and membership organizations, including fundraising, volunteer management, membership administration, and advocacy tools.

Enterprise SoftwareImpact & Social GoodSaaS

Co-investorsWaterloo Accelerator Centre Andreessen Horowitz BHP Ventures Breakthrough Energy Ventures Earthshot Ventures Entourage Ventures +6 more

Firecellfirecell.io in 𝕏Feb 2026

Firecell provides turnkey Private 5G network solutions for enterprises in manufacturing, logistics, ports, airports, mines, energy, research, and defense.

HardwareIoTRobotics

Co-investorsKima Ventures Matterwave Ventures Bpifrance Cogito Capital Partners Ventech

Flindrflindrtx.com in 𝕏

Flindr is a biotech company developing small molecule inhibitors for cancer treatment using its ImmunoGram Drug Discovery Engine to identify novel therapeutic targets in cancer and immune cells.

AI & Machine LearningBiotechDeep TechHealthtechGhent, BE

Maarten Ligtenberg(Founder / Chief Executive Officer)Prof. Daniel Peeper(Founder)Prof. Christian Blank(Founder)

Co-investorsBOM V-Bio Ventures

Innocensinnocens.be inAug 2026

Innocens develops an on-premise data platform for hospitals that collects, synchronizes, and annotates high-frequency time-series medical data from clinical devices, designed specifically for neonatal ICU applications.

AI & Machine LearningData & InfrastructureDigital HealthMedical DevicesBrussels, BE

David Van Laere(Founder)in

Co-investorsAllusion

MoveUpmoveup.care

moveUP provides digital platforms for healthcare delivery, offering patient engagement programs, healthcare professional collaboration tools, and real-world data collection across specialties including orthopedics, bariatrics, oncology, and cardiology.

Digital HealthHealthtechSaaS

Co-investorsImpact Expansion Management Sarl Karista Nina Capital NovaCapital

MRM Healthmrmhealth.com in

MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsAthos VIB Korys

Rainbow Cropsrainbowcrops.com

Rainbow Crops applies AI, genome engineering, and field validation to help seed and breeding companies develop crops with complex traits such as yield stability and drought, heat, and disease resilience.

AgTechAI & Machine LearningBiotech

Co-investorsAgri Investment Fund LIFTT Maia Ventures PINC AIF VIB

Sentiancesentiance.com in 𝕏Nov 2015

Sentiance provides AI-powered on-device behavioral intelligence for mobile applications, turning sensor data into real-time insights about driving patterns, mobility, and lifestyle.

AI & Machine LearningData & InfrastructureInsurTechIoTMobility & TransportationSaaS

Co-investorsCuriosity VC KPN Ventures Samsung Catalyst Fund Volta Ventures Pamica NV

THERAtRAMEtheratrame.com in

THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments.

AI & Machine LearningBiotechMedical DevicesLiège, BE

Francesca Rapino(CEO)in Pierre Close(CSO)in

Co-investorsWallonie Entreprendre

Trincetrincebio.com in

Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation.

BiotechDeep TechMedical DevicesGent, BE

Philip

Co-investorsNovalis Biotech

Uniflyunifly.aero in 𝕏Nov 2016

Unifly develops a unified traffic management platform for drone and urban air mobility operators, offering end-to-end services from flight planning and validation through execution and post-flight reporting.

HardwareIoTLogistics & Supply ChainMobility & TransportationRoboticsSaaS

Co-investorsPMV

VoxelSensorsvoxelsensors.comMay 2023

Ultra-low power, ultra-low latency 3D perception sensors for extended reality.

Co-investorsCapricorn Venture Partners imec.istart

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AILOSBlue FooteyeoFlindr TherapeuticsPleeviSighteraSightera BiosciencesSpica TherapeuticsSwaveTanai TherapeuticsWeavely

Portfolio news

latest coverage across their companies

Vylor and Rainbow Crops Partner to Accelerate Development of Novel Gene-Edited Corn Traits

Rainbow Crops · prnewswire.com · Sep 21, 2026

Innocens Raises €1.5M Pre-Seed

Innocens · thesaasnews.com · Aug 11, 2026

Belgium's MRM Health raises €55 million for microbiome-based biotherapeutic product pipeline | EU-Startups

MRM Health · eu-startups.com · Sep 4, 2025

Belgian BioTech developer AmphiStar secures €12.5 million for clean biosurfactants | EU-Startups

AmphiStar · eu-startups.com · Jul 9, 2025

Frequently asked questions

How many investments has Qbic Fund made?: Qbic Fund has 33 tracked investments, including 5 dated in the last 24 months.
What stage does Qbic Fund invest at?: Qbic Fund invests at the Pre-Seed, Seed, Series A stages.
What sectors does Qbic Fund focus on?: Qbic Fund focuses on Advanced Manufacturing, AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Crypto & Web3, Deep Tech, Digital Health, Energy, FoodTech, Hardware, Healthtech, Impact & Social Good, IoT, Medical Devices, Mobility & Transportation, New Materials, Quantum Computing, Robotics, SaaS, Sector Agnostic, Semiconductors, Space Tech.
Where is Qbic Fund located?: Qbic Fund is headquartered in St-Denijs-Westrem, BE.
Does Qbic Fund lead rounds?: Qbic Fund typically participates in rounds rather than leading them.
Who does Qbic Fund co-invest with?: Qbic Fund most often shares deals with imec.istart, PMV, Agri Investment Fund, among 23 tracked co-investors.

Similar investors

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.

$250K

BDC Fund Investments (Fund-of-Funds)

This page is the analysis and research library of BDC (Business Development Bank of Canada), listing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses and the venture capital landscape.

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$5K – $50M

MPG Fund

MPG Fund is an early-stage venture investor backing technology startups.

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M